Schwartz Lauren E, Khani Francesca, Bishop Justin A, Vang Russell, Epstein Jonathan I
Departments of *Pathology †Gynecology and Obstetrics ‡Urology §Oncology, The Johns Hopkins Medical Institutions, Baltimore, MD.
Am J Surg Pathol. 2016 Jan;40(1):27-35. doi: 10.1097/PAS.0000000000000524.
Uterine cervical carcinoma secondarily involving the genitourinary tract is rarely documented histologically. These tumors present a unique diagnostic challenge as they can appear morphologically similar to urothelial carcinoma as well as primary squamous cell carcinoma and primary adenocarcinoma of the bladder. Genitourinary consult cases at the Johns Hopkins Hospital from 1984 to the present were searched for cases in which the differential diagnosis was primary bladder carcinoma versus secondary involvement by cervical carcinoma. We identified 10 cases that met these criteria and evaluated them by immunohistochemistry for p16 and GATA3 and in situ hybridization for human papillomavirus (HPV). Six cases were received with a gynecologic history. Four cases had been misdiagnosed as urothelial carcinoma, and 1 case was favored to be cystitis cystica et glandularis by the submitting institutions. Morphologically, the majority of cases showed basaloid nests of tumor cells infiltrating muscle bundles, with several having foci that mimicked urothelial carcinoma in situ. Six tumors were found to be diffusely positive with p16, 1 tumor was patchy, 1 was weak, and 2 were negative. GATA3 staining was negative in 6 cases, and 4 showed weak to strong positivity. Eight cases were positive for high-risk HPV (6 were positive for HPV 16, and 1 was positive for HPV 18). In the 2 cases that were negative for HPV by in situ hybridization, characteristic morphologic features of HPV-unrelated type of endocervical adenocarcinoma were present. On the basis of our findings we advocate a multifaceted approach, combining morphologic evaluation with ancillary studies including immunohistochemistry and in situ hybridization in the evaluation of genitourinary specimens for secondary involvement by cervical carcinoma. Furthermore, gynecologic clinical history is absolutely critical and most important to the evaluation and diagnosis of these specimens, as these ancillary studies are not completely sensitive or specific.
子宫颈癌继发累及泌尿生殖道的组织学记录很少。这些肿瘤带来了独特的诊断挑战,因为它们在形态上可能与尿路上皮癌以及膀胱原发性鳞状细胞癌和原发性腺癌相似。检索了1984年至今约翰霍普金斯医院的泌尿生殖科会诊病例,以寻找鉴别诊断为原发性膀胱癌与子宫颈癌继发累及的病例。我们确定了10例符合这些标准的病例,并通过免疫组织化学检测p16和GATA3以及人乳头瘤病毒(HPV)原位杂交进行评估。6例有妇科病史。4例曾被误诊为尿路上皮癌,1例被送检机构倾向诊断为腺性膀胱炎。形态学上,大多数病例显示肿瘤细胞的基底样巢状结构浸润肌束,有几例有类似原位尿路上皮癌的病灶。6例肿瘤p16弥漫阳性,1例呈斑片状,1例弱阳性,2例阴性。6例GATA3染色阴性,4例呈弱阳性至强阳性。8例高危HPV阳性(6例HPV 16阳性,1例HPV 18阳性)。在2例原位杂交HPV阴性的病例中,存在HPV无关类型的宫颈腺癌的特征性形态学特征。基于我们的发现,我们提倡采用多方面的方法,在评估泌尿生殖标本是否继发子宫颈癌累及的过程中,将形态学评估与包括免疫组织化学和原位杂交在内的辅助研究相结合。此外,妇科临床病史对于这些标本的评估和诊断绝对至关重要,因为这些辅助研究并不完全敏感或特异。